- Home
- VTYX vs SNBR Comparison
VTYX vs SNBR Comparison
Compare VTYX & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- SNBR
- Stock Information
- Founded
- VTYX 2018
- SNBR 1987
- Country
- VTYX United States
- SNBR United States
- Employees
- VTYX N/A
- SNBR N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- SNBR Home Furnishings
- Sector
- VTYX Health Care
- SNBR Consumer Discretionary
- Exchange
- VTYX Nasdaq
- SNBR Nasdaq
- Market Cap
- VTYX 154.9M
- SNBR 161.7M
- IPO Year
- VTYX 2021
- SNBR 1998
- Fundamental
- Price
- VTYX $3.65
- SNBR $6.20
- Analyst Decision
- VTYX Buy
- SNBR Hold
- Analyst Count
- VTYX 3
- SNBR 2
- Target Price
- VTYX $10.00
- SNBR $9.00
- AVG Volume (30 Days)
- VTYX 1.5M
- SNBR 425.6K
- Earning Date
- VTYX 11-06-2025
- SNBR 10-29-2025
- Dividend Yield
- VTYX N/A
- SNBR N/A
- EPS Growth
- VTYX N/A
- SNBR N/A
- EPS
- VTYX N/A
- SNBR N/A
- Revenue
- VTYX N/A
- SNBR $1,524,620,000.00
- Revenue This Year
- VTYX N/A
- SNBR N/A
- Revenue Next Year
- VTYX N/A
- SNBR $0.88
- P/E Ratio
- VTYX N/A
- SNBR N/A
- Revenue Growth
- VTYX N/A
- SNBR N/A
- 52 Week Low
- VTYX $0.78
- SNBR $4.48
- 52 Week High
- VTYX $4.05
- SNBR $20.73
- Technical
- Relative Strength Index (RSI)
- VTYX 62.22
- SNBR 30.91
- Support Level
- VTYX $3.48
- SNBR $5.84
- Resistance Level
- VTYX $4.04
- SNBR $6.42
- Average True Range (ATR)
- VTYX 0.30
- SNBR 0.39
- MACD
- VTYX 0.04
- SNBR -0.05
- Stochastic Oscillator
- VTYX 72.93
- SNBR 25.24
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.